- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
The prospects of pazopanib in advanced renal cell carcinoma - Abstract
November 29, 2013
Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib - Abstract
November 29, 2013
Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: Role of MDCT - Abstract
November 29, 2013
Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: A multicenter study of 556 patients - Abstract
November 29, 2013
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up - Abstract
November 28, 2013
Predictive factors for the development of chronic renal insufficiency after renal surgery: A multicenter study - Abstract
November 28, 2013
Bone-targeted therapies for elderly patients with renal cell carcinoma: Current and future directions - Abstract
November 27, 2013
Shrinkage of prostate volume in sunitinib-treated patients with renal cell carcinoma - Abstract
November 26, 2013
Spontaneous regression of metastatic pulmonary renal cell carcinoma in the setting of sarcomatoid differentiation of the primary tumour - Abstract
November 26, 2013
Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: Factors influencing patient survival - Abstract
November 26, 2013
Pharmacological therapy of urogenital cancer: Rational routine diagnostic imaging - Abstract
November 25, 2013
Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma - Abstract
November 22, 2013
Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma - Abstract
November 22, 2013
Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma - Abstract
November 22, 2013